Lymphoma Trial, Recruiting (NCT04425421)

Lymphoma Trial, Recruiting NCT04425421 Sponsor: French Africa Pediatric Oncology Group Condition: Lymphoma

Printed from Voxsanity (voxsanity.com.au) — NCT04425421 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lymphoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child has been diagnosed with Burkitt's Lymphoma (a type of cancer), in any location in the body
The diagnosis has been confirmed by a laboratory test looking at cells or tissue samples
The child is not able to receive or complete the full standard treatment

Who may not be able to join:

The child's cancer is not a B cell type tumor (a specific type of cancer cell) (confirm with trial site)
The child has already received treatment for this condition before
The child has another illness or health condition that would make the treatment unsafe or unsuitable for them
The child's parents or guardians do not give their consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04425421

Sponsor: French Africa Pediatric Oncology Group

Phase: Not Applicable

Status: Recruiting

Condition: Lymphoma

More information: https://clinicaltrials.gov/study/NCT04425421

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child has been diagnosed with Burkitt's Lymphoma (a type of cancer), in any location in the body
The diagnosis has been confirmed by a laboratory test looking at cells or tissue samples
The child is not able to receive or complete the full standard treatment

Who may not be able to join:

The child's cancer is not a B cell type tumor (a specific type of cancer cell) (confirm with trial site)
The child has already received treatment for this condition before
The child has another illness or health condition that would make the treatment unsafe or unsuitable for them
The child's parents or guardians do not give their consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

French Africa Pediatric Oncology Group

Registry

ClinicalTrials.gov

Start date

1 November 2020

Est. completion

31 December 2028

Where this trial is recruiting

Burkina Faso Côte d’Ivoire Democratic Republic of the Congo Madagascar Mali Senegal

Primary endpoints

Evaluation of the number of cases with local disease.; Evaluation of the number of cases by stage at the time of diagnosis.; Evaluating the treatment given.; Evaluating the follow up after treatment.; Number of relapse cases

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov